[Effect of hexabendin on oxygen consumption, energetics and substrate metabolism of the heart. II. Studies with intravenously administered single doses].
D000588:Amines / Q000494:pharmacology; D000818:Animals; D001786:Blood Glucose; D001795:Blood Pressure Determination; D002245:Carbon Dioxide; D003331:Coronary Vessels; D004285:Dogs; D004562:Electrocardiography; D005029:Ethylenediamines / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects*; D007263:Infusions, Parenteral; D007773:Lactates / Q000032:analysis; D009206:Myocardium / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology*
D000588:Amines; D001786:Blood Glucose; D005029:Ethylenediamines; D007773:Lactates; D014665:Vasodilator Agents; D002245:Carbon Dioxide
Die Wirkung von Hexobendin auf Sauerstoffverbrauch, Energetik und Substratstoffwechsel des Herzens.